Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02420990 · ClinicalTrials.gov registry record · NA
Integrated Treatment for Adolescents With ADHD
A NA study, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 145
- Enrollment target
NCT02420990 is a NA study that has completed, run by The National Center on Addiction and Substance Abuse at Columbia University. The registered enrollment target is 145 participants.
The verdict
NCT02420990, a NA study, has completed, sponsored by The National Center on Addiction and Substance Abuse at Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 145 participants
- Enrollment target
Study Summary
Attention-Deficit/Hyperactivity Disorder (ADHD) exists in 20-50% of the 3 million adolescents annually enrolled in outpatient mental health and substance use treatment. Adolescents with ADHD present deficits in attention, self-regulation, and social competence that significantly impede achievement of developmental and educational milestones. Currently there are only two evidence-based treatment options for this age group: academic training and stimulant medications. Both options remain vastly underutilized. Academic training is not available in most school settings and rarely implemented in clinical care. Similarly, ADHD medications are rarely utilized with adolescents in primary or specialty care for a host of reasons related to stigma, misinformation about effects and side effects, and adolescent autonomy issues. Moreover, the widespread fragmentation of pharmacological versus behavioral services prevents families from making informed treatment selections. The primary objective of this randomized parametric trial is to compare the effectiveness of behavioral only versus integrated (behavioral plus medication decision-making) interventions for adolescents with ADHD in outpatient behavioral services. The behavioral intervention, Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA), contains three components: ADHD psychoeducation, family-based motivational interventions, and academic training. The medication decision-making intervention, Medication Integration Protocol (MIP), contain three components: psychoeducation about ADHD medication, family decision-making, and medication management. The study will compare the effects of two legitimate treatment options for adolescents with ADHD on service utilization, behavioral symptoms, and quality of life. It will generate new evidence on patient-centered treatment selection that aligns with family-specific principles and treatment goals. This parametric comparative trial will randomly assign 140 inne
Interventions
- BEHAVIORAL Medication Integration Protocol (MIP)
- BEHAVIORAL Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 145 participants |
| Start Date | 2015-03-01 |
| Est. Completion | 2018-08-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02420990
The ClinicalTrials.gov registry entry for NCT02420990 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 145 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Medication Integration Protocol (MIP) is the first listed.
NCT02420990 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02420990 about?
NCT02420990 is a clinical study titled "Integrated Treatment for Adolescents With ADHD". Attention-Deficit/Hyperactivity Disorder (ADHD) exists in 20-50% of the 3 million adolescents annually enrolled in outpatient mental health and substance use treatment. Adolescents with ADHD present deficits in attention, self-regulation, and social competence that significantly impede achievement o...
What is the current status of trial NCT02420990?
This trial is currently completed. It is a NA study. The enrollment target is 145 participants. The study started on 2015-03-01. Estimated completion is 2018-08-31.
What interventions are being tested in trial NCT02420990?
The interventions under investigation include: Medication Integration Protocol (MIP) (BEHAVIORAL), Changing Academic Support in the Home for Adolescents with ADHD (CASH-AA) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02420990?
This trial is sponsored by The National Center on Addiction and Substance Abuse at Columbia University, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.